[5 -fluoropyrimidines for treatment of biliary tract cancers]

Nihon Rinsho. 2006 Jan:64 Suppl 1:529-33.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / administration & dosage
  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biliary Tract Neoplasms / drug therapy*
  • Capecitabine
  • Clinical Trials as Topic
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • Drug Combinations
  • Fluorouracil / analogs & derivatives
  • Humans
  • Oxonic Acid / administration & dosage
  • Pyridines / administration & dosage
  • Pyrimidines* / administration & dosage
  • Pyrimidines* / pharmacology
  • Tegafur / administration & dosage
  • Uracil / administration & dosage

Substances

  • Antineoplastic Agents
  • Drug Combinations
  • Pyridines
  • Pyrimidines
  • Deoxycytidine
  • S 1 (combination)
  • Tegafur
  • Uracil
  • Oxonic Acid
  • 5-fluoropyrimidine
  • Capecitabine
  • Fluorouracil

Supplementary concepts

  • 1-UFT protocol